28 Jul 2010 10:36
ο»Ώ
|
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES |
||||||||||
|
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: |
ARK THERAPEUTICS GROUP PLC |
|||||||||
|
2 Reason for the notification (please tick the appropriate box or boxes): |
||||||||||
|
Β An acquisition or disposal of voting rights |
x |
|||||||||
|
Β An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
|
|||||||||
|
Β An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
|
|||||||||
|
Β An event changing the breakdown of voting rights |
|
|||||||||
|
Β Other (please specify): |
|
|
||||||||
|
3. Full name of person(s) subject to the notification obligation: Β |
Β Gartmore Investment Limited |
|||||||||
|
4. Full name of shareholder(s) (if different from 3.): Β |
Registered Owner: BNY GIL CLT Account Nominees Ltd Β Beneficial Owner: Gartmore Fledgling Trust PLC |
|||||||||
|
5. Date of the transaction and date on which the threshold is crossed or reached: Β |
Β 23 July 2010 |
|||||||||
|
6. Date on which issuer notified: Β |
Β 27 July 2010 |
|||||||||
|
7. Threshold(s) that is/are crossed or reached: Β |
Β 5% |
|||||||||
|
8. Notified details: |
||||||||||
|
A: Voting rights attached to shares Β |
||||||||||
|
Class/type of shares if possible using the ISIN CODE |
Situation previous to the triggering transaction |
Resulting situation after the triggering transaction |
||||||||
|
Number of Shares |
Number of Voting Rights |
Number of shares |
Number of voting rights |
% of voting rights |
||||||
|
Direct |
Direct |
Indirect |
Direct |
Indirect |
||||||
|
Β Ordinary GB0034251727 |
Β - |
- |
10,610,000 |
|
10,610,000 |
|
5.075% |
|||
|
|
||||||||||
Β
|
B: Qualifying Financial Instruments |
|||||||||
|
Resulting situation after the triggering transaction Β |
|||||||||
|
Type of financial instrument |
Expiration date |
Exercise/ Conversion Period |
Number of voting rights that may be acquired if the instrument is exercised/ converted. Β |
% of voting rights |
|||||
|
Β N/A |
|
|
|
|
|||||
|
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments |
|||||||||
|
Resulting situation after the triggering transaction Β |
|||||||||
|
Type of financial instrument |
Exercise price |
Expiration date |
Exercise/ Conversion period |
Number of voting rights instrument refers to |
% of voting rights Β |
||||
|
Β N/A |
|
|
|
|
Nominal |
Delta Β |
|||
|
|
|
||||||||
|
Total (A+B+C) Β |
|||||||||
|
Number of voting rights |
Percentage of voting rights |
||||||||
|
Β 10,610,000 |
5.075% |
||||||||
|
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: |
|||||||||
|
|
|||||||||
|
Proxy Voting: Β |
|||||||||
|
10. Name of the proxy holder: Β |
|
||||||||
|
11. Number of voting rights proxy holder will cease to hold: Β |
|
||||||||
|
12. Date on which proxy holder will cease to hold voting rights: Β |
|
||||||||
|
13. Additional information: Β |
Β Email contact: RDU@gartmore.com |
||||||||
|
14. Contact name: Β |
Β RDU |
||||||||
|
15. Contact telephone number: Β |
Β 0207 782 2324 |
||||||||
Β
Follow the stocks